Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; maize starch; silicon dioxide; gelatin; magnesium stearate - ursodeoxycholic acid is indicated in the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: magnesium stearate; colloidal anhydrous silica; maize starch; titanium dioxide; iron oxide yellow; gelatin - ursodox gh (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodeoxycholic acid lapl (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: magnesium stearate; maize starch; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodeoxycholic acid lupin (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: maize starch; colloidal anhydrous silica; pregelatinised maize starch; magnesium stearate; titanium dioxide; gelatin; sodium lauryl sulfate; sorbitan monolaurate - ursosan is indicated in the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; titanium dioxide; maize starch; gelatin; sodium lauryl sulfate; magnesium stearate; purified water - the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule - excipient ingredients: silicon dioxide; gelatin; titanium dioxide; maize starch; magnesium stearate - ursodeoxycholic acid is indicated in the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodox lupin (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; maize starch; magnesium stearate; titanium dioxide; iron oxide yellow; gelatin - ursodox lapl (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: povidone; sodium lauryl sulfate; maize starch; magnesium stearate; titanium dioxide; gelatin; purified water - treatment of chronic cholestatic liver diseases.